MedPath

Take it Personal!+: a personalized treatment for substance use disorder in people with mild intellectual disability and borderline intellectual functioning

Recruiting
Conditions
Substance use disorder, intellectual disabilities
Registration Number
NL-OMON26987
Lead Sponsor
ZonMw Mr. F. Couvee stichting
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

1) A MID-BIF (IQ between 60-85),
2) diagnosed with a mild or moderate substance use disorder according to the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; APA, 2013) in cannabis, alcohol, XTC, cocaine or speed,
3) use the substance on at least three days of the week,
4) proficient in Dutch language, and
5) has a network (professional and/or social) that is able to support the treatment goals of the client.

Exclusion Criteria

1) Risk of withdrawal symptoms,
2) severe psychiatric comorbidity, such as suicidality, psychosis or major depressive disorder,
3) severe somatic problems, and
4) psychosocial problems that interfere with treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Substance use assessed with a daily diary method during the baseline phase, intervention phase and post treatment. <br><br>
Secondary Outcome Measures
NameTimeMethod
Personal and social recovery assessed with the standardized questionnaire ‘Ben ik tevreden?’ (BIT) (Van Biene, 2014) during baseline phase, post-treatment and follow-up phase.<br><br>Craving, positive and negative affect assessed with the daily diary method during the baseline phase, intervention phase and post-treatment (e.g. How happy were you today? Did you have a desire to use the substance today?)<br><br>Substance use measured with the Substance Use and Misuse in Intellectual Disability - Questionnaire (SUMID-Q) (Van Der Nagel, Kiewik, Van Dijk, De Jong, & Didden, 2011) <br>
© Copyright 2025. All Rights Reserved by MedPath